These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 29675916)
1. Serum ApoA4 levels predicted the progression of renal impairment in T2DM. Cheng CW; Chang CC; Chen HW; Lin CY; Chen JS Eur J Clin Invest; 2018 Jun; 48(6):e12937. PubMed ID: 29675916 [TBL] [Abstract][Full Text] [Related]
2. Osteoinductive factor is a novel biomarker for the diagnosis of early diabetic nephropathy. Wang S; Wang Y; Zheng R; Zhao Z; Ma Y Int J Clin Exp Pathol; 2015; 8(3):3110-5. PubMed ID: 26045825 [TBL] [Abstract][Full Text] [Related]
3. Serum CXCL16 as a novel marker of renal injury in type 2 diabetes mellitus. Zhao L; Wu F; Jin L; Lu T; Yang L; Pan X; Shao C; Li X; Lin Z PLoS One; 2014; 9(1):e87786. PubMed ID: 24489966 [TBL] [Abstract][Full Text] [Related]
4. Implication of decreased serum complement 3 in patients with diabetic nephropathy. Zhang J; Wang Y; Zhang R; Li H; Han Q; Guo R; Wang T; Li L; Liu F Acta Diabetol; 2018 Jan; 55(1):31-39. PubMed ID: 29043511 [TBL] [Abstract][Full Text] [Related]
5. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients. El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886 [TBL] [Abstract][Full Text] [Related]
6. Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus. Nie F; Wu D; Du H; Yang X; Yang M; Pang X; Xu Y J Diabetes Complications; 2017 Mar; 31(3):594-598. PubMed ID: 27916483 [TBL] [Abstract][Full Text] [Related]
7. Association of reduced red blood cell deformability and diabetic nephropathy. Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255 [TBL] [Abstract][Full Text] [Related]
8. Association of serum pentraxin 3 concentrations with diabetic nephropathy. Wang R; Zhang J; Hu W J Investig Med; 2016 Aug; 64(6):1124-7. PubMed ID: 27233528 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Serum Micro-RNA 152-3p in Type 2 Diabetes Mellitus with a Significant Elevation in Progressive Nephropathy. Nasser M; Ibrahim KMF; Elnabawi WM; Ahmed TM Egypt J Immunol; 2020 Jun; 27(2):81-92. PubMed ID: 33548980 [TBL] [Abstract][Full Text] [Related]
10. The Level of Serum Albumin Is Associated with Renal Prognosis in Patients with Diabetic Nephropathy. Zhang J; Zhang R; Wang Y; Li H; Han Q; Wu Y; Wang T; Liu F J Diabetes Res; 2019; 2019():7825804. PubMed ID: 30911552 [TBL] [Abstract][Full Text] [Related]
11. ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus. Zhang P; Gao J; Pu C; Feng G; Wang L; Huang L; Zhang Y Clin Chim Acta; 2017 Mar; 466():31-37. PubMed ID: 28073663 [TBL] [Abstract][Full Text] [Related]
12. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836 [TBL] [Abstract][Full Text] [Related]
13. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy. Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887 [TBL] [Abstract][Full Text] [Related]
14. Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy. Conti G; Caccamo D; Siligato R; Gembillo G; Satta E; Pazzano D; Carucci N; Carella A; Campo GD; Salvo A; Santoro D Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31591338 [No Abstract] [Full Text] [Related]
15. Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: Differential expression profile of circulating lncRNA . Yang Y; Lv X; Fan Q; Wang X; Xu L; Lu X; Chen T Clin Nephrol; 2019 Jul; 92(1):25-35. PubMed ID: 31079598 [TBL] [Abstract][Full Text] [Related]
16. Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus. Zhang J; Wang Y; Zhang R; Li H; Han Q; Wu Y; Wang S; Guo R; Wang T; Li L; Liu F Diabetes Res Clin Pract; 2018 Jul; 141():1-9. PubMed ID: 29684616 [TBL] [Abstract][Full Text] [Related]
17. [Correlation between cognitive impairment and diabetic nephropathy in patients with Type 2 diabetes mellitus]. Shi X; Zhang Y; Niu H; Wang R; Shen J; Zhou S; Yang H; Wang S; Wu J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):143-50. PubMed ID: 26932211 [TBL] [Abstract][Full Text] [Related]
18. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy. Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059 [TBL] [Abstract][Full Text] [Related]
19. Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy. Xu T; Xu X; Zhang L; Zhang K; Wei Q; Zhu L; Yu Y; Xiao L; Lin L; Qian W; Wang J; Ke M; An X; Liu S Front Endocrinol (Lausanne); 2021; 12():781417. PubMed ID: 34956093 [TBL] [Abstract][Full Text] [Related]
20. Proteome analysis of serum from type 2 diabetics with nephropathy. Kim HJ; Cho EH; Yoo JH; Kim PK; Shin JS; Kim MR; Kim CW J Proteome Res; 2007 Feb; 6(2):735-43. PubMed ID: 17269729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]